The differences of standard therapy for breast cancer between Europe/America and Japan--chemotherapy, operation,and radiotherapy
Kitagawa, D.; Saji, S.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(5): 690-693
2007
ISSN/ISBN: 0385-0684 PMID: 17496438 Document Number: 615004
As increased incidence of breast cancer, the concept of standard therapy based on the evidence based medicine (EBM) has been widely applied to breast cancer treatment in Japan. Since the major parts of evidences are common in Western countries and Japan,general treatment strategy for standard care seems to be identical in both countries. However, there are still some differences due to the limited usages of anti-cancer drugs and supporting drugs. We would discuss about these issues in this paper.
Document emailed within 1 workday
Related Documents
Ogawa, K.; Nakamura, K.; Onishi, H.; Sasaki, T.; Koizumi, M.; Shioyama, Y.; Komiyama, T.; Miyabe, Y.; Teshima, T. 2006: Radical external beam radiotherapy for clinically localized prostate cancer in Japan: differences in the patterns of care between Japan and the United States Anticancer Research 26(1b): 575-580Kienle, G. 1981: Mistletoe therapy of breast cancer in comparison with chemotherapy and radiotherapy ZFA. Zeitschrift für Allgemeinmedizin 57(5): 328-337
Kanda, K.; Waki, S.; Uchimura, M.; Kida, H.; Narita, K.; Harada, N. 1990: A case of bone and lung metastasis of breast cancer successfully treated with radiotherapy, chemotherapy and endocrine therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2421-2424
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
Hendry, J. 2013: An Anthropologist of Japan from Europe Looks at the Anthropology of Europe from Japan - Un anthropologue du Japon en Europe regarde l'anthropologie de l'Europe du Japon International Workshop the Anthropology of Europe and its Extending Horizons (81): 185-188
Tashiro, H. 2000: Standard chemotherapy for metastatic breast cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 246-253
von Schrader-Beielstein, A. 2000: Travel pharmacy for the physician. 1: On the road in Europe, North America and Japan MMW Fortschritte der Medizin 142(19): 41-42
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Ohsumi, S.; Takashima, S.; Saeki, T.; Aogi, K. 2002: Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer Center Biomedicine and PharmacoTherapy 56(Suppl): 196s-200s
Evans, R.A. 1998: Radiotherapy and chemotherapy in high-risk breast cancer New England Journal of Medicine 338(5): 331; Author Reply 331-332
Borger, J.; Bartelink, H. 1996: Does the sequence of radiotherapy and chemotherapy in breast-conserving therapy influence outcome? Cancer Journal from Scientific American 2(1): 19-20
Osawa, G.; Yoshimatsu, K.; Yokomizo, H.; Otani, T.; Yano, Y.; Itagaki, H.; Matsumoto, A.; Fujimoto, T.; Umehara, A.; Ogawa, K. 2010: A case of multiple lung and liver metastases from colon cancer treated with clinical benefit by hepatic arterial infusion chemotherapy plus cetuximab mono-therapy after standard chemotherapy failure Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2526-2528
Raina, V.; Sharma, A.; Deo, S.V.; Shukla, N.K.; Mohanty, B.K.; Goel, A.; Rath, G.K. 1998: Mitoxantrone, mitomycin-C, methotrexate combination chemotherapy with radiotherapy and/or surgery in stage IIi (T4B, NO-2, M0) breast cancer Journal of the Association of Physicians of India 46(11): 926-929
Bleehen, N.M. 1973: Radiotherapy, chemotherapy and surgical therapy in the treatment of cancer Recenti Progressi in Medicina 54(5): 422-443
Kaufmann, M.; Jonat, W.; Eiermann, W.; Maass, H.; Bastert, G. 1990: Breast saving operation and adjuvant therapy of breast cancer. Report of the National Institute of Health (NIH) consensus development conference, Washington, D.C., USA, 18-21 June 1990 Onkologie 13(5): 394-396
Rühl, U. 2000: Consolidation radiotherapy after high-dose chemotherapy and autologous bone marrow transplantation in patients with advanced breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 176(4): 196-197
Ikeda, T. 1994: "State of the art" of adjuvant chemo-endocrine therapy for breast cancer in Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(Suppl 3): 370-376
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Moro, K.; Nagahashi, M.; Tsuchida, J.; Tatsuda, K.; Toshikawa, C.; Hasegawa, M.; Ishikawa, T.; Shimada, Y.; Sakata, J.; Kameyama, H.; Kobayashi, T.; Minagawa, M.; Kosugi, S-ichi.; Koyama, Y.; Wakai, T. 2015: Locally Advanced Breast Cancer Treated with Halsted's Operation Because of Drug-Induced Lung Injury Caused by Neoadjuvant Chemotherapy--A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1803-1805
Rainer, H. 1985: Prospective randomized clinical trial: protoadjuvant chemotherapy vs. protoadjuvant radiotherapy in breast cancer stages T3/4, N+/-, M0 Wiener Medizinische Wochenschrift 135(23-24): 599-602